J.Jpn. Surg. Soc.
ISSN 1880-1129

[Abstract] [Full Text HTML] [Full Text PDF] （in Japanese / 2020KB） [PDF: Members Only]

J.Jpn. Surg. Soc.. 122(1): 26-31, 2021

Feature topic

TREATMENT OF ATYPICAL BRONCHOPULMONARY CARCINOIDS

1) Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan
2) Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan

Toshi Menju1), Akihiko Yoshizawa2), Hiroshi Date1)

Typical and atypical bronchopulmonary carcinoid (TC, AC) tumors are classified as intermediate-grade neuroendocrine tumors of the lung. However, AC tumors have more aggressive potential and worse prognosis than TC tumors. The current standard therapy for ACs is surgical resection in operable cases. Lobectomy with lymph node dissection is the standard procedure for AC, which is the same as for lung cancer. For inoperable cases, several chemotherapeutic regimens are available. However, no standard medical treatment has yet been established. Multimodal treatment for locally advanced AC tumors remains to be determined in the future.

<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.